Polo-like kinase 1 promotes pulmonary hypertension

被引：0
|
作者：
Rongrong Chen
Hongfei Wang
Cuiting Zheng
Xiyu Zhang
Li Li
Shengwei Wang
Hongyu Chen
Jing Duan
Xian Zhou
Haiyong Peng
Jing Guo
Anchen Zhang
Feifei Li
Wang Wang
Yu Zhang
Jun Wang
Chen Wang
Yan Meng
Xinling Du
Hongbing Zhang
机构：
[1] Peking Union Medical College and Chinese Academy of Medical Sciences,State Key Laboratory of Common Mechanism Research for Major Diseases, Haihe Laboratory of Cell Ecosystem, Department of Physiology, Institute of Basic Medical Sciences and School of Basic
[2] Huazhong University of Science and Technology,Department of Cardiac Surgery, Institute of Cardiovascular Disease, Union Hospital, Tongji Medical College
[3] Capital Medical University,Department of Pathology, Beijing Lab for Cardiovascular Precision Medicine, Key Laboratory of Medical Engineering for Cardiovascular Disease
[4] Capital Medical University,Department of Physiology
[5] Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
来源：
Respiratory Research | / 24卷
关键词：
Pulmonary hypertension; Hypoxia; Polo-like kinase 1; HIF1α; RELA/p65;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Polo-like kinase 1 promotes pulmonary hypertension
    Chen, Rongrong
    Wang, Hongfei
    Zheng, Cuiting
    Zhang, Xiyu
    Li, Li
    Wang, Shengwei
    Chen, Hongyu
    Duan, Jing
    Zhou, Xian
    Peng, Haiyong
    Guo, Jing
    Zhang, Anchen
    Li, Feifei
    Wang, Wang
    Zhang, Yu
    Wang, Jun
    Wang, Chen
    Meng, Yan
    Du, Xinling
    Zhang, Hongbing
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [2] Application of a Fluorescence Recovery-Based Polo-Like Kinase 1 Binding Assay to Polo-Like Kinase 2 and Polo-Like Kinase 3
    Tsuji, Kohei
    Tamamura, Hirokazu
    Burke Jr, Terrence R.
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (07) : 1282 - 1287
  • [3] WAC Promotes Polo-like Kinase 1 Activation for Timely Mitotic Entry
    Qi, Feifei
    Chen, Qinfu
    Chen, Hongxia
    Yan, Haiyan
    Chen, Binbin
    Xiang, Xingfeng
    Liang, Cai
    Yi, Qi
    Zhang, Miao
    Cheng, Hankun
    Zhang, Zhenlei
    Huang, Jun
    Wang, Fangwei
    CELL REPORTS, 2018, 24 (03): : 546 - 556
  • [4] The balance of Polo-like kinase 1 in tumorigenesis
    Lin-Yu Lu
    Xiaochun Yu
    Cell Division, 4
  • [5] The CINs of Polo-Like Kinase 1 in Cancer
    Cunningham, Chelsea E.
    MacAuley, Mackenzie J.
    Vizeacoumar, Frederick S.
    Abuhussein, Omar
    Freywald, Andrew
    Vizeacoumar, Franco J.
    CANCERS, 2020, 12 (10) : 1 - 26
  • [6] The balance of Polo-like kinase 1 in tumorigenesis
    Lu, Lin-Yu
    Yu, Xiaochun
    CELL DIVISION, 2009, 4
  • [7] Polo-like kinase 1 promotes sepsis-induced myocardial dysfunction
    Gao, Zhenqiang
    Zheng, Cuiting
    Xing, Yaqi
    Zhang, Xiyu
    Bai, Yunfei
    Chen, Chen
    Zheng, Yuanyuan
    Wang, Wen
    Zhang, Hongbing
    Meng, Yan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [8] Developing polo-like kinase 1 inhibitors
    Huang, Xufeng
    Xie, Zhouling
    Liao, Chenzhong
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (10) : 869 - 871
  • [9] Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1
    Berg, Angela
    Berg, Thorsten
    CHEMBIOCHEM, 2016, 17 (08) : 650 - 656
  • [10] Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells
    Pezuk, Julia Alejandra
    Brassesco, Maria Sol
    Manzini Ramos, Priscila Maria
    Scrideli, Carlos Alberto
    Tone, Luiz Gonzaga
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (09) : 1278 - 1291
12345